Time critical in infectious uveitis

Article

Diagnosis based on clinical findings, duration and progression, inflammation, retina

Infectious uveitis is usually diagnosed based on the clinical findings with consideration of the duration and progression of the disorder, the appearance of the inflammation, and the extent of the retinal involvement.

"When faced with advanced cases of posterior uveitis, with a presumed infection, time is of the essence," said Dr Young, associate professor of ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachussetts, USA. "Available diagnostic polymerase chain reaction (PCR) testing has been shown to be extremely useful for detecting a wide range of pathogens, particularly viral pathogens."

Differentiating uveitic infections

The differential diagnosis in patients with vitritis includes toxoplasmic retinitis, acute retinal necrosis, endophthalmitis, tuberculosis, syphilis, sarcoidosis, autoimmune diseases, intraocular lymphoma and Toxocara infections.

An important step in these cases is a thorough history.

"The rates of progression and duration are the most important bits of information," Dr Young said. "Don't be fooled if a patient presents with 2 to 3 days of increased ocular redness and pain. This does not mean that the patient has had this for only 2 to 3 days. Once a true 2- to 3-day course of rapid progression has been established, acute retinal necrosis or bacterial endophthalmitis must be considered."

At the other end of the spectrum, if a patient cannot accurately define the time of progression, syphilis or tuberculosis might be considerations, but in these cases, a rapid diagnosis is not as pressing as in acute cases. In cases in which the patient has been symptomatic for weeks, Toxoplasma infection and fungal endophthalmitis are considerations, she advised.

Determining the status of the patient's immune system is important. If a patient appears healthy and robust, progressive outer retinal necrosis (PORN) and cytomegalovirus (CMV) retinitis are likely not issues.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.